Ipilimumab retreatment following induction therapy: The expanded access program (EAP) experience

被引：0
|
作者：
Margolin, Kim Allyson
Hamid, Omid
Weber, Jeffrey S.
Pavlick, Anna C.
Hodi, F. Stephen
Amin, Asim
Bennett, Kelly
Michener, Tracy
Minor, David R.
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Angeles Clin & Res Inst, Los Angeles, CA USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Comprehens Melanoma Res Ctr, Tampa, FL USA
[4] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Levine Canc Inst, Charlotte, NC USA
[7] Bristol Myers Squibb, Plainsboro, NJ USA
[8] Calif Pacific Ctr Melanoma Res & Treatment, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9041
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Spanish experience with the ipilimumab Expanded Access Program.
    Berrocal, Alfonso
    Lopez-Martin, Jose A.
    Maria Arance, Ana
    Soriano, V.
    Espinosa, Enrique
    Lopez Criado, M. Pilar
    Munoz, Eva
    Pablo Berros, Jose
    Soria, A.
    Marquez, I.
    Sancho, P.
    Gil, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] SPANISH MELANOMA MULTIDISCIPLINARY GROUP (GEM) EXPERIENCE WITH IPILIMUMAB (IPI) IN THE EXPANDED ACCESS PROGRAMME (EAP)
    Martin Algarra, S.
    Alonso, L.
    Valdivia, J.
    Garcia Castano, A.
    Escrig, V.
    Mut, P.
    Ballesteros, A.
    Puertolas, T.
    Ortega, E.
    Berrocal, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 374 - 374
  • [3] Ipilimumab in the real world: The UK expanded access programme (EAP) experience in advanced melanoma.
    Ahmad, Saif
    Qian, Wendi
    Ellis, Sarah Gabrielle
    Khattak, Muhammad Adnan
    Gupta, Avinash
    Thillai, Kiruthikah
    Board, Ruth E.
    Nobes, Jenny
    Dalgleish, Angus
    Grumett, Simon Aird
    Maraveyas, Anthony
    Danson, Sarah
    Talbot, Toby
    Marples, Maria
    Plummer, Ruth
    Kumar, Satish
    Middleton, Mark R.
    Larkin, James M. G.
    Ottensmeier, Christian
    Corrie, Philippa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program
    Berrocal, Alfonso
    Arance, Ana
    Lopez Martin, Jose Antonio
    Soriano, Virtudes
    Munoz, Eva
    Alonso, Lorenzo
    Espinosa, Enrique
    Lopez Criado, Pilar
    Valdivia, Javier
    Martin Algarra, Salvador
    MELANOMA RESEARCH, 2014, 24 (06) : 577 - 583
  • [5] A single-institution experience with the pembrolizumab (PEM) Expanded Access Program (EAP)
    Perdon, Karen Mae
    Kim, Dae Won
    Balmes, Gener C.
    VanAnh Trinh
    McIntyre, Susan E.
    Diab, Adi
    Amaria, Rodabe Navroze
    Patel, Sapna Pradyuman
    Hwu, Patrick
    James, Marihella
    Philip, Ann
    Vardeleon, Anna
    Cain, Suzanne
    Hwu, Wen-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] NUSINERSEN FOR SMA1: THE ITALIAN EXPANDED ACCESS PROGRAM (EAP) EXPERIENCE
    Albamonte, E.
    Pane, M.
    Messina, S.
    D'Amico
    Bertini, E.
    Bruno, C.
    Vita, G.
    Casiraghi, J.
    Binetti, L.
    Mercuri, E.
    Sansone, V. A.
    MUSCLE & NERVE, 2017, 56 : S2 - S3
  • [7] IPILIMUMAB FOR ADVANCED MELANOMA IN AN EXPANDED ACCESS PROGRAMME (EAP): OCULAR, MUCOSAL AND ACRAL SUBTYPE UK EXPERIENCE
    Shaw, H.
    Larkin, J.
    Corrie, P.
    Ellis, S.
    Nobes, J.
    Marshall, E.
    Kumar, S.
    Danson, S.
    Plummer, R.
    Nathan, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 374 - 374
  • [8] The use of nusinersen in the "real world": the UK and Ireland experience with the expanded access program (EAP)
    Scoto, M.
    Manzue, A.
    Main, M.
    Munot, P.
    Tillmann, R.
    Bettolo, C. Marini
    Mayhew, A.
    Muni-Lofra, R.
    White, K.
    Baxter, P.
    Tirupathi, S.
    Douglas, I.
    Douglas, M.
    Macauley, S.
    Childs, A-M
    O'Rourke, D.
    Hartley, L.
    Hughes, I.
    McCullagh, G.
    Spinty, S.
    Madhu, R.
    Gregson, S.
    Gowda, V.
    Wraige, E.
    Horrocks, I.
    Brunklaus, A.
    Di Marco, M.
    Dunne, J.
    Brown, S.
    Mochrie, R.
    Illingworth, M.
    Krishnakumar, D.
    Kirkpatrick, M.
    Ramdas, S.
    Vijayakumar, K.
    Selby, V.
    Kulshrestha, R.
    Willis, T.
    Straub, V.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S25 - S25
  • [9] Pembrolizumab Expanded Access Program (EAP) in Taiwan for patients with progressive advanced melanoma after prior ipilimumab treatment
    Yang, C-K.
    Liu, J-H.
    Lin, C-C.
    Liu, T-C.
    Cheng, P-T.
    Lin, C-Y.
    Hu, H-T.
    Cao, C-R.
    Huang, W-T.
    Chen, L-P.
    Chang, W-C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] Expanded access program (EAP) to investigational drugs.
    Talarico, L
    Pazdur, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 519S - 519S
12345